Hypocellular AML versus MDS-diagnostic challenge case report with review of literature

Ravi Jacob1, Himanshu Dhanda1, Sartaj Ali1

  • 1ICMR-National Institute of Pathology, Safdarjung Hospital Campus New Delhi, India.

Insights

Hypocellular acute myeloid leukemia (AML) presents diagnostic challenges due to overlapping features with other conditions. Clearer understanding is crucial for accurate patient management and treatment decisions.

Area of Science:

  • Hematology
  • Oncology
  • Pathology

Background:

  • Hypocellular acute myeloid leukemia (AML) is a rare subtype with overlapping clinical and pathological features.
  • Differentiating hypocellular AML from Myelodysplastic Syndromes (MDS) is challenging due to inherent dysplasia in AML.

Observation:

  • A case report details an elderly male patient presenting with fever, pallor, weight loss, fatigue, and hepatomegaly.
  • The patient, unable to afford advanced treatment, received only supportive care and succumbed shortly thereafter.

Findings:

  • Diagnostic dilemmas in hypocellular AML are highlighted, particularly when bone marrow cellularity is below 10%.
  • The case underscores the need for improved understanding to distinguish hypocellular AML from other hematological disorders.

Implications:

  • Enhanced diagnostic clarity for hypocellular AML is essential for effective therapeutic patient management.
  • Further research and literature enrichment are needed to address the limited published data on this rare AML subtype.

Related Concept Videos